Overview

Effectiveness of Clozapine Versus Olanzapine for Treatment-resistant Schizophrenia

Status:
Completed

Trial end date:
2002-06-01

Target enrollment:

Participant gender:

Summary

This study will determine the effectiveness of clozapine versus olanzapine in treating people with schizophrenia that has not improved with treatment.

Phase:

Phase 4

Details

Lead Sponsor:

Harvard Medical School
Harvard Medical School (HMS and HSDM)

Collaborators:

Commonwealth Research Center, Massachusetts
Dartmouth-Hitchcock Medical Center
Eli Lilly and Company
National Institute of Mental Health (NIMH)

Treatments:

Clozapine
Olanzapine